摘要
目的探讨去上皮快速角膜交联术紫外光脉冲输出模式(pl-快速CXL)和经上皮pl-快速CXL治疗进展期圆锥角膜患者的临床效果。方法选取2018年1月至2019年6月在河北省眼科医院行pl-快速CXL治疗的进展期圆锥角膜患者16例31眼;根据术式将患眼分为两组,去上皮pl-快速CXL组7例13眼和经上皮pl-快速CXL组9例18眼。术前及术后3个月和6个月进行随访。记录患眼最佳矫正远视力、散光度、角膜前表面最大曲率、角膜前表面最小曲率、角膜最薄点厚度、角膜内皮细胞计数、交联线深度,对各指标进行统计学分析。结果去上皮pl-快速CXL组和经上皮pl-快速CXL组患者术后3个月和术后6个月最佳矫正远视力、散光度、角膜前表面最大曲率、角膜前表面最小曲率、角膜内皮细胞计数与术前相比,差异均无统计学意义(均为P>0.05);术后3个月和术后6个月时两组角膜最薄点厚度均较术前变薄,差异均有统计学意义(均为P<0.05)。两组患者交联线深度术后3个月与术后6个月相比,差异均无统计学意义(均为P>0.05)。术后3个月和术后6个月时,去上皮pl-快速CXL组患者角膜交联线深度均较经上皮pl-快速CXL组更深,差异均有统计学意义(均为P<0.05)。对于相同时间点的其他参数而言,两组间差异均无统计学意义(均为P>0.05)。结论无论是去上皮pl-快速CXL还是经上皮pl-快速CXL都安全可行,在术后6个月内均能够稳定圆锥角膜病情。
Objective To evaluate the clinical efficacy of epithelium-off accelerated corneal cross-linking(Epi-off ACXL)and epithelium-on accelerated corneal cross-linking(Epi-on ACXL)using pulsed ultraviolet light(pl)for keratoconus.Methods The data of 16 patients(31 eyes)performed with Epi-off pl-ACXL and Epi-on pl-ACXL in Hebei Eye Hospital from January 2018 to June 2019 was included and separated into two groups,the Epi-off pl-ACXL group(7 patients 13 eyes)and the Epi-on pl-ACXL group(9 patients 18 eyes).Follow-ups were performed before and 3 months and 6 months after surgery.The two groups were compared in best corrected distance visual acuity(BCDVA),astigmatism,maximum and minimum keratometry,corneal thinnest point thickness,corneal endothelial cells,and depth of demarcation line pre-and postoperatively.Results No statistically difference was found between two groups in the parameters of BCDVA,astigmatism,maximum and minimum keratometry,and corneal endothelial cells between 3 months and 6 months after surgery and before surgery(all P>0.05).The corneal thinnest point thickness decreased significantly at 3 months and 6 months after surgery when compared with before surgery in the two groups(P<0.05).There was no significant differences between the two groups of patients in depth of demarcation line 3 months and 6 months after surgery(both P>0.05).At 3 months and 6 months after surgery,the depth of demarcation line of the patients in the Epi-off pl-ACXL group was deeper than that in the Epi-on pl-ACXL group group,and the difference was statistically significant(all P<0.05).For other parameters at the same time point,there was no statistically significant differences between the two groups(all P>0.05).Conclusion Both Epi-off pl-ACXL and Epi-on pl-ACXL are safe and feasible treatment for keratoconus both of which can stabilise symptoms.
作者
王萌萌
王晶晶
刘延东
李明然
尹会苏
张印博
董兴国
WANG Mengmeng;WANG Jingjing;LIU Yandong;LI Mingran;YIN Huisu;ZHANG Yinbo;DONG Xingguo(Hebei Provincial Key Laboratory of Ophthalmology,Refractive Treating Department,Hebei Provincial Eye Hospital,Xingtai 054001,Hebei Province,China)
出处
《眼科新进展》
CAS
北大核心
2020年第11期1037-1040,共4页
Recent Advances in Ophthalmology
基金
国家自然科学基金资助(编号81700873)
河北省重点研发计划项目(编号18277754D)
河北省医学科学研究课题计划项目(编号20200842)
河北省中医药管理局科研计划项目(编号2020553)
邢台市科技支撑计划项目(编号2016ZC262)。
关键词
圆锥角膜
角膜交联术
角膜缘
紫外光
核黄素
keratoconus
corneal cross-linking
limbus
ultraviolet
riboflavin